Growth Metrics

Biofrontera (BFRI) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.

  • Biofrontera's Consolidated Net Income fell 1728.7% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 3688.56%. This contributed to the annual value of -$17.8 million for FY2024, which is 1178.28% up from last year.
  • Latest data reveals that Biofrontera reported Consolidated Net Income of -$6.6 million as of Q3 2025, which was down 1728.7% from -$5.3 million recorded in Q2 2025.
  • Biofrontera's Consolidated Net Income's 5-year high stood at $5.6 million during Q1 2022, with a 5-year trough of -$16.0 million in Q3 2021.
  • Over the past 5 years, Biofrontera's median Consolidated Net Income value was -$4.2 million (recorded in 2025), while the average stood at -$4.9 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first soared by 25735.71% in 2022, then tumbled by 197159.53% in 2025.
  • Quarter analysis of 5 years shows Biofrontera's Consolidated Net Income stood at -$14.5 million in 2021, then surged by 80.8% to -$2.8 million in 2022, then soared by 226.61% to $3.5 million in 2023, then crashed by 139.59% to -$1.4 million in 2024, then crashed by 376.29% to -$6.6 million in 2025.
  • Its last three reported values are -$6.6 million in Q3 2025, -$5.3 million for Q2 2025, and -$4.2 million during Q1 2025.